NCT06770335

Brief Summary

Medical treatments have improved survival rates for children with brain tumours. However, most children experience long-term difficulties with 'cognition' (thinking skills such as memory and paying attention) and cognitive fatigue (excessive mental tiredness) after treatment. Thinking difficulties and fatigue can affect a child's ability to learn, and their social and emotional wellbeing. National guidance recommends treatment called 'cognitive rehabilitation' which teaches skills to improve or manage cognitive difficulties. Families often request this, but it is not usually available due to little research. Fatigue may also get in the way of children using and benefiting from cognitive rehabilitation. No research study has offered a fatigue treatment for children recovering from brain tumours. The study aims to see if it is practical and helpful to families to provide cognitive rehabilitation for children affected by brain tumours. The treatment focuses on strategies to help cognition. The investigators will see if adding strategies to manage fatigue helps. The study will include thirty-six 7-17-year-olds who have been treated for brain tumour at Great Ormond Street Hospital. All participants will have had an assessment describing cognitive strengths and weaknesses as part of usual care. Participants will be randomly allocated to one of three groups: 1) cognitive rehabilitation with fatigue management (12 weeks), 2) cognitive rehabilitation only (6 weeks), or 3) usual care. Each child and their carer will complete questionnaires before, during, and after the treatment, and an interview at the end of the treatment. This information will help the researchers see if families find the treatment helpful and practical to take part in, and if adding fatigue strategies is beneficial. Researchers will look at information such as the number of appointments attended, feedback about the treatment, and information about fatigue levels, cognition, and wellbeing. The findings will be used to develop a UK-wide study.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Mar 2025Dec 2026

First Submitted

Initial submission to the registry

December 24, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 13, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

March 10, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

January 13, 2025

Status Verified

January 1, 2025

Enrollment Period

1.8 years

First QC Date

December 24, 2024

Last Update Submit

January 7, 2025

Conditions

Keywords

Paediatric brain tumourcognitive rehabilitationcognitionfatiguefeasibilityacceptabilityneuropsychologyneurocognitivechildhood brain tumour

Outcome Measures

Primary Outcomes (2)

  • Goal Based Outcome for management of fatigue

    The GBO tool is a way of evaluating progress towards goals in clinical work with children, young people, and their families and carers. The GBO compares how far a child or young person feels they have moved towards reaching a goal that they have set for themselves at the beginning of an intervention, on a scale between 0 and 10. 1-3 therapeutic goals are developed collaboratively with a psychologist

    From enrolment to week 14

  • Goal Based Outcome for management of cognitive difficulty

    The GBO tool is a way of evaluating progress towards goals in clinical work with children, young people, and their families and carers. The GBO compares how far a child or young person feels they have moved towards reaching a goal that they have set for themselves at the beginning of an intervention, on a scale between 0 and 10. 1-3 therapeutic goals are developed collaboratively with a psychologist

    From enrolment to week 14

Secondary Outcomes (6)

  • Multidimensional Fatigue Scale

    From enrolment to week 14

  • Individual daily fatigue analogue scale

    From enrolment to week 14

  • % School attendance

    From enrolment to week 14

  • Behaviour Rating Inventory of Executive Function, Second Edition (BRIEF2)

    From enrolment to week 14

  • Paediatric Quality of Life Inventory (PedsQL) Core + Brain Tumour Module Cognitive Problems scale

    From enrolment to week 14

  • +1 more secondary outcomes

Study Arms (3)

Cognitive rehabilitation with fatigue management

EXPERIMENTAL

A 12-week block of intervention (strategy-based cognitive rehabilitation with fatigue management)

Behavioral: THE FATIGUE, LEARNING, AND MEMORY ENRICHMENT (FLaME) INTERVENTION - Full intervention

Cognitive rehabilitation only

EXPERIMENTAL

A 6-week block of intervention (strategy-based cognitive rehabilitation alone)

Behavioral: THE FATIGUE, LEARNING, AND MEMORY ENRICHMENT (FLaME) INTERVENTION - Cognitive rehabilitation only

Standard care

NO INTERVENTION

Standard care only

Interventions

A novel strategy-based cognitive rehabilitation intervention that can be delivered with or without cognitive fatigue management. Skills are targeted sequentially based on a developmental hierarchical model where cognitive fatigue can be addressed first, followed by adult-supported compensatory strategies, with independent use of strategies for specific impairments delivered only once these earlier levels have been addressed. The 'FLaME' program incorporates strategies that have been trialled and found successful in fatigue (e.g., pacing and activity scheduling) and cognitive rehabilitation (e.g., chunking, elaborative encoding techniques) interventions for children. The intervention address two key issues: 1) to deliver strategy-based cognitive rehabilitation as an alternative to prevailing drill-based approaches, and 2) to integrate fatigue management to improve feasibility and acceptability of cognitive rehabilitation. This arm include the full intervention.

Cognitive rehabilitation with fatigue management

A novel strategy-based cognitive rehabilitation intervention that can be delivered with or without cognitive fatigue management. Skills are targeted sequentially based on a developmental hierarchical model where cognitive fatigue can be addressed first, followed by adult-supported compensatory strategies, with independent use of strategies for specific impairments delivered only once these earlier levels have been addressed. The 'FLaME' program incorporates strategies that have been trialled and found successful in fatigue (e.g., pacing and activity scheduling) and cognitive rehabilitation (e.g., chunking, elaborative encoding techniques) interventions for children. The intervention address two key issues: 1) to deliver strategy-based cognitive rehabilitation as an alternative to prevailing drill-based approaches, and 2) to integrate fatigue management to improve feasibility and acceptability of cognitive rehabilitation. This arm includes the cognitive rehabilitation only.

Cognitive rehabilitation only

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age range: 7 years to 17 years, 11 months.
  • Received diagnosis and/or treatment/surveillance at GOSH for a childhood tumour that involved the CNS (brain) and/or oncology treatment to brain.
  • Received or receiving a neuropsychological assessment/consultation at GOSH over the course of the study period or in the 48 months prior to the study period, or under active surveillance with the neuro-oncology multidisciplinary team during the study period.
  • At least 6 months post-diagnosis/acute treatment (surgery and/or radiotherapy), and 3 months post-return to school, with stable disease.
  • One or more scores outside of normal limits (i.e. 1 SD above or below the mean in the direction indicating difficulty) in at least one neuropsychological domain (on performance-based tests or questionnaire-based rating scales).
  • Report impairment (z-score \> -0.67) in fatigue on one or more subscales of the PedsQL Multidimensional Fatigue Scale.
  • Capacity/competence of patient or parent/carer to provide informed

You may not qualify if:

  • Completed or having another targeted formal psychological intervention for cognitive rehabilitation or fatigue in the past 6 months.
  • Sensorimotor (e.g., visual-motor) impairment only on neuropsychological assessment without additional cognitive difficulty.
  • Current substance misuse from self-report.
  • Currently receiving formal psychiatric care for a diagnosed mental health disorder (including active suicidal ideation), excluding ADHD treatment (if a child has a diagnosis of ADHD they should be treated).
  • Intellectual Disability based on a standard score of more than 2 standard deviations below the mean on a general adaptive behaviour composite and, where available, the General Ability Index of intellect.
  • Patient and parent/carer is unable to communicate verbally and in written form in English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Great Ormond Street Hospital for Children

London, London, WC1N 3JH, United Kingdom

Location

Related Publications (7)

  • Irestorm E, Ora I, Linge H, Tonning Olsson I. Cognitive Fatigue and Processing Speed in Children Treated for Brain Tumours. J Int Neuropsychol Soc. 2021 Oct;27(9):865-874. doi: 10.1017/S1355617720001332. Epub 2021 Jan 14.

    PMID: 33441219BACKGROUND
  • Patel SK, Katz ER, Richardson R, Rimmer M, Kilian S. Cognitive and problem solving training in children with cancer: a pilot project. J Pediatr Hematol Oncol. 2009 Sep;31(9):670-7. doi: 10.1097/MPH.0b013e3181b25a1d.

    PMID: 19707159BACKGROUND
  • Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, Noll RB, Patel SK, Sahler OJ. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol. 2008 Jun;76(3):367-78. doi: 10.1037/0022-006X.76.3.367.

    PMID: 18540731BACKGROUND
  • Simons DJ, Boot WR, Charness N, Gathercole SE, Chabris CF, Hambrick DZ, Stine-Morrow EA. Do "Brain-Training" Programs Work? Psychol Sci Public Interest. 2016 Oct;17(3):103-186. doi: 10.1177/1529100616661983.

    PMID: 27697851BACKGROUND
  • Hocking MC, Paltin I, Quast LF, Barakat LP. Acceptability and Feasibility in a Pilot Randomized Clinical Trial of Computerized Working Memory Training and Parental Problem-Solving Training With Pediatric Brain Tumor Survivors. J Pediatr Psychol. 2019 Jul 1;44(6):669-678. doi: 10.1093/jpepsy/jsz015.

    PMID: 30874803BACKGROUND
  • Treadgold B, Kennedy C, Spoudeas H, Sugden E, Walker D, Bull K. Paediatric neuro-oncology rehabilitation in the UK: carer and provider perspectives. BMJ Paediatr Open. 2019 Dec 15;3(1):e000567. doi: 10.1136/bmjpo-2019-000567. eCollection 2019.

    PMID: 31909222BACKGROUND
  • Lassaletta A, Bouffet E, Mabbott D, Kulkarni AV. Functional and neuropsychological late outcomes in posterior fossa tumors in children. Childs Nerv Syst. 2015 Oct;31(10):1877-90. doi: 10.1007/s00381-015-2829-9. Epub 2015 Sep 9.

    PMID: 26351237BACKGROUND

Related Links

MeSH Terms

Conditions

Fatigue

Interventions

Educational StatusCASP8 and FADD-Like Apoptosis Regulating Protein

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation CharacteristicsDeath Domain Receptor Signaling Adaptor ProteinsAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsPeptidesAmino Acids, Peptides, and ProteinsTumor Necrosis Factor Receptor-Associated Peptides and ProteinsApoptosis Regulatory ProteinsCarrier ProteinsProteins

Study Officials

  • Charlotte P Malcolm, DClinPsy

    Great Ormond Street Hospital for Children NHS Foundation Trust

    PRINCIPAL INVESTIGATOR
  • Faraneh Vargha-Khadem, PhD

    Great Ormond Street Hospital for Children NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Charlotte P Malcolm, DClinPsy

CONTACT

Tara Murphy, DClinPsy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The feasibility study employs a randomised, parallel arm design with a standard care control group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 24, 2024

First Posted

January 13, 2025

Study Start

March 10, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

January 13, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations